BTIG Research Initiates Histogenics With Buy

Analysts at BTIG Research initiated coverage on shares of
Histogenics Corporation
HSGX
with a Buy rating. The target price for Histogenics is set to $13. Histogenics' shares closed at $8.43 yesterday.

Posted In: BTIG ResearchInitiationAnalyst Ratings